These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 28135707)

  • 1. Changes in Oral Anticoagulant Treatment Rates in Atrial Fibrillation before and after the Introduction of Direct Oral Anticoagulants.
    Shah RU; Rupp AB; Mowery D; Zhang M; Stoddard G; Deshmukh V; Bray BE; Hess R; Rondina MT
    Neuroepidemiology; 2016; 47(3-4):201-209. PubMed ID: 28135707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of Direct Oral Anticoagulants on Rates of Oral Anticoagulation for Atrial Fibrillation.
    Marzec LN; Wang J; Shah ND; Chan PS; Ting HH; Gosch KL; Hsu JC; Maddox TM
    J Am Coll Cardiol; 2017 May; 69(20):2475-2484. PubMed ID: 28521884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Tasmanian atrial fibrillation study: Transition to direct oral anticoagulants 2011-2015.
    Alamneh EA; Chalmers L; Bereznicki LR
    Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28177198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS
    Katz DF; Maddox TM; Turakhia M; Gehi A; O'Brien EC; Lubitz SA; Turchin A; Doros G; Lei L; Varosy P; Marzec L; Hsu JC
    Circ Cardiovasc Qual Outcomes; 2017 May; 10(5):. PubMed ID: 28506981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of oral anticoagulants in atrial fibrillation is highly variable and only weakly associated with estimated stroke risk: cross-sectional population database study.
    Dreischulte T; Barnett K; Madhok V; Guthrie B
    Eur J Gen Pract; 2014 Sep; 20(3):181-9. PubMed ID: 24351017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Restraints to anticoagulation prescription in atrial fibrillation and attitude towards the new oral anticoagulants].
    Pereira-Da-Silva T; Souto Moura T; Azevedo L; Sá Pereira M; Virella D; Alves M; Borges L
    Acta Med Port; 2013; 26(2):127-32. PubMed ID: 23809744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profiling of patients with non-valvular atrial fibrillation and moderate-to-high risk of stroke not receiving oral anticoagulation in Spain.
    Polo García J; Vargas Ortega D; Formiga F; Unzueta I; Fernández de Cabo S; Chaves J
    Semergen; 2019 Sep; 45(6):396-405. PubMed ID: 30573367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification of In-Hospital Recommendation and Prescription of Anticoagulants for Secondary Prevention of Stroke after Launch of Direct Oral Anticoagulants and Change of National Guidelines.
    Gronemann C; Hause S; Assmann A; Neumann J; Schreiber S; Heinze HJ; Goertler M
    Cerebrovasc Dis; 2020; 49(4):412-418. PubMed ID: 32756054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporal Trends in the Use and Comparative Effectiveness of Direct Oral Anticoagulant Agents Versus Warfarin for Nonvalvular Atrial Fibrillation: A Canadian Population-Based Study.
    Yu AYX; Malo S; Svenson LW; Wilton SB; Hill MD
    J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29080863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in Oral Anticoagulant Prescribing for Stroke Prevention in Patients With Atrial Fibrillation.
    Admassie E; Chalmers L; Bereznicki LR
    Am J Cardiol; 2017 Oct; 120(7):1133-1138. PubMed ID: 28781025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors influencing oral anticoagulant use in patients newly diagnosed with atrial fibrillation.
    Bezabhe WM; Bereznicki LR; Radford J; Wimmer BC; Curtain C; Salahudeen MS; Peterson GM
    Eur J Clin Invest; 2021 May; 51(5):e13457. PubMed ID: 33222261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy persistence in newly diagnosed non-valvular atrial fibrillation treated with warfarin or NOAC. A cohort study.
    Martinez C; Katholing A; Wallenhorst C; Freedman SB
    Thromb Haemost; 2016 Jan; 115(1):31-9. PubMed ID: 26246112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Appropriateness of prescription of oral anticoagulant therapy in acutely hospitalized older people with atrial fibrillation. Secondary analysis of the SIM-AF cluster randomized clinical trial.
    Antoniazzi S; Ardoino I; Proietti M; Monzani V; Mannucci PM; Nobili A; Franchi C;
    Br J Clin Pharmacol; 2019 Sep; 85(9):2134-2142. PubMed ID: 31218738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prescription of oral anticoagulants and antiplatelets for stroke prophylaxis in atrial fibrillation: nationwide time series ecological analysis.
    Wu J; Alsaeed ES; Barrett J; Hall M; Cowan C; Gale CP
    Europace; 2020 Sep; 22(9):1311-1319. PubMed ID: 32778878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of care in patients with atrial fibrillation in primary care: a cross-sectional study comparing clinical and claims data.
    Preuss R; Chenot JF; Angelow A
    Ger Med Sci; 2016; 14():Doc13. PubMed ID: 27980520
    [No Abstract]   [Full Text] [Related]  

  • 16. Adoption of direct oral anticoagulants for stroke prevention in atrial fibrillation.
    Baker D; Wilsmore B; Narasimhan S
    Intern Med J; 2016 Jul; 46(7):792-7. PubMed ID: 27040617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in Use of Anticoagulation in Patients With Atrial Fibrillation Within a Primary Care Network Associated With the Introduction of Direct Oral Anticoagulants.
    Ashburner JM; Singer DE; Lubitz SA; Borowsky LH; Atlas SJ
    Am J Cardiol; 2017 Sep; 120(5):786-791. PubMed ID: 28693744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors Influencing Oral Anticoagulation Prescription for Patients Presenting to Emergency Departments With Atrial Fibrillation and Flutter.
    Miller RJH; Chew DS; Rezazadeh S; Klassen S; Pournazari P; Lang E; Quinn FR
    Can J Cardiol; 2018 Jun; 34(6):804-807. PubMed ID: 29801744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substantial differences in initiation of oral anticoagulant therapy and clinical outcome among non-valvular atrial fibrillation patients treated in inpatient and outpatient settings.
    Mikkelsen AP; Hansen ML; Olesen JB; Hvidtfeldt MW; Karasoy D; Husted S; Johnsen SP; Brandes A; Gislason G; Torp-Pedersen C; Lamberts M
    Europace; 2016 Apr; 18(4):492-500. PubMed ID: 26443443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in Atrial Fibrillation and Prescription of Oral Anticoagulants and Embolic Strokes in Germany.
    Guelker JE; Bufe A; Klues H; Shin DI; Blockhaus C; Gabriel NH; Haverkamp W; Kroeger K
    Cardiovasc Revasc Med; 2019 May; 20(5):399-402. PubMed ID: 30115560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.